Ke Peng
- Pharmaceutical Science top 0.2%
- Advancements in Transdermal Drug Delivery 17
- Advanced Drug Delivery Systems 13
- Virology top 2%
- HIV Research and Treatment 8
- Molecular Medicine top 1%
- Biomaterials top 1%
- Infectious Diseases top 1%
- Viral Infections and Vectors 12
- SARS-CoV-2 and COVID-19 Research 8
- HIV/AIDS drug development and treatment 8
-
- Dermatology and Skin Diseases 10
-
- interferon and immune responses 9
- Co-authors
- Alexander KrosItsuro TomatsuZhong ZhangRyan F. DonnellyLalitkumar K. VoraShufen LiIsmaiel A. TekkoLuqi Liu
- Journals
- International Journal of Pharmaceutics (7 papers)Journal of Virology (6 papers)ACS Applied Materials & Interfaces (4 papers)
- Partner nations
- ChinaUnited KingdomNetherlands
In The Last Decade
Ke Peng
151 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Pharmaceutical Science 953
- Virology 379
- Molecular Medicine 376
- Biomaterials 707
- Infectious Diseases 972
Countries citing papers authored by Ke Peng
This map shows the geographic impact of Ke Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Peng more than expected).
Fields of papers citing papers by Ke Peng
This network shows the impact of papers produced by Ke Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Peng. The network helps show where Ke Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ke Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 7 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 33 | |
| 12 | 2021 | 53 | |
| 13 | 2021 | 20 | |
| 14 | 2020 | 10 | |
| 15 | 2019 | 141 | |
| 16 | 2019 | 5 | |
| 17 | 2019 | 41 | |
| 18 | 2019 | 73 | |
| 19 | 2018 | 14 | |
| 20 | Volatile Constituents and Their Antimicrobial Activities of Endophytic Fungus Aspergillus sp. A14 from Aquilaria sinensis | 2011 | 2 |
About Ke Peng
Ke Peng is a scholar working on Pharmaceutical Science, Virology, Infectious Diseases, Molecular Medicine and Dermatology, having authored 156 papers that have together received 5.6k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (17 papers), Advanced Drug Delivery Systems (13 papers), Viral Infections and Vectors (12 papers), Dermatology and Skin Diseases (10 papers), interferon and immune responses (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (8 papers). The work is most often cited by research in Pharmaceutical Science (953 citations), Virology (379 citations), Molecular Medicine (376 citations), Biomaterials (707 citations) and Infectious Diseases (972 citations). Ke Peng has collaborated with scholars based in China, United Kingdom and Netherlands. Frequent co-authors include Alexander Kros, Itsuro Tomatsu, Zhong Zhang, Ryan F. Donnelly, Lalitkumar K. Vora, Shufen Li, Ismaiel A. Tekko, Luqi Liu, Yu Jia and Xinglong Gong. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Virology, ACS Applied Materials & Interfaces, Journal of Controlled Release and ACS Applied Bio Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.